Nextech Invest Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 24
Professionals
  • Investments
  • 69
  • Portfolio
  • 17
  • Exits
  • 35
Exits

Nextech Invest General Information

Description

Founded in 1998, Nextech is a global, cancer therapeutics-focused venture capital firm based in Zurich, Switzerland. The firm prefers to invest in the life science, biotechnology, and oncology sector.

Contact Information

Year Founded
1998
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Bahnhofstrasse 18
  • 8001 Zurich
  • Switzerland
+41 044 000 00 00

Nextech Invest Investments (69)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Hexagon Bio 15-Jul-2021 Later Stage VC 0000 Drug Discovery Generating Revenue 00000 00000 00.0
000000 000000 16-Jun-2021 00000 00000 0000 Drug Discovery Generating Revenue 00000 000000000 00.0
00000 000000000000 13-May-2021 00000 00000 0000 Drug Discovery Pre-Clinical Trials
000000000 000 28-Apr-2021 00000 00000 00000 Drug Discovery Generating Revenue 00000 00000 00.0
0000 00000000000 31-Mar-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials 0000000 000000000 00.0
00000000 000000000 01-Feb-2021 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 00000 00000 00.0
0000 11-Jan-2021 00000 00000 00000 Drug Discovery Startup
00000000 000000000 07-Jan-2021 00000 00000 00000 Drug Discovery Startup
Cullinan Oncology 17-Dec-2020 Later Stage VC 00000 Drug Discovery Pre-Clinical Trials
IconOVir Bio 11-Dec-2020 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 00000 00000 00.0
You’re viewing 10 of 69 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nextech Invest Exits (35)

Company Name Exit Date Exit Type Exit Size
Cullinan Oncology 08-Jan-2021 IPO 00000
0000000000 0000000 04-Dec-2020 000 00000
0000000 000000000 03-Dec-2020 000 00000
000000 000 09-Oct-2020 000 00000
00 000000000000 02-Oct-2020 000 00000
000 000000 25-Sep-2020 000 00000
0000000000 0000000 13-Feb-2020 000 00000
000000000 00000000 23-Jan-2020 000000 0000000000 00000
Peloton Therapeutics 11-Jul-2019 Merger/Acquisition 00.000
IDEAYA Biosciences 23-May-2019 IPO 0000
You’re viewing 10 of 35 exits. Get the full list »

Nextech Invest Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nextech Invest Team (38)

Name Title Deals Funds Boards Office
Marco Weibel Chief Financial Officer Zurich, Switzerland
Thomas Lips Ph.D General Partner Zurich, Switzerland
Alfred Scheidegger Ph.D Founder & Partner 0 0 Zurich, Switzerland
Jakob Loven Ph.D Partner 00 0 0 Zurich, Switzerland
Rocco Sgobbo Partner Zurich, Switzerland
You’re viewing 5 of 38 team members. Get the full list »

Nextech Invest Co-Investors (150)

Name With Exits Lead Partner Series Industry
Boxer Capital 12 0 Series chart Industry bar
Casdin Capital 00 0 0 Series chart Industry bar
RA Capital Management 00 0 00 Series chart Industry bar
Logos Capital 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
You’re viewing 5 of 150 co-investors. Get the full list »